Skip to content

Clinical trials

Phase 3 Dermatitis, Atopic trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis, Atopic Phase: Phase 3 Country / region: United Kingdom Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20131
20142
20151
20161
20173
201811
20194
20201
20211
20221
20236
20245
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Active, not recruiting6
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
LEO Pharma7
AbbVie6
Regeneron Pharmaceuticals6
Pfizer5
Amgen4
Astellas Pharma Inc3
Sanofi3
Almirall, S.A.2
Eli Lilly and Company2
Incyte Corporation2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis, Atopic41
Eczema14
Dermatitis2
Skin Diseases2
Genetic Diseases, Inborn1
Hypersensitivity1
Hypersensitivity, Immediate1
Immune System Diseases1
Pruritus1
Skin Diseases, Eczematous1

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.